Clinical Trial Update: Lung Cancer Risk in Type 2 Diabetes With COPD: SGLT2 Inhibitors vs. Sulfonylureas

View source ↗

Summary

This clinical trial update notes a completed study comparing SGLT2 inhibitors versus sulfonylureas in people with type 2 diabetes and COPD to evaluate lung canc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease
• Lung Cancer
• Type 2 Diabetes Mellitus

Drugs mentioned

• SGLT2 inhibitors (SGLT2 inhibitor)
• Sulfonylureas

Snippet

Sponsor: Samsung Medical Center | Conditions: Type 2 Diabetes, COPD (Chronic Obstructive Pulmonary Disease) | Status: COMPLETED